Compare Erasca Inc. Common Stock (ERAS) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.92 (market cap $5.40B), while Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.3× Erasca Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Erasca Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| ERAS | HALO | |
|---|---|---|
Market Cap | $5.40B | $12.58B |
Volume | 9,533,185 | 2,179,278 |
Sector | Health | Health |
52-Week High | $22.47 | $115.22 |
52-Week Low | $2.20 | $61.63 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.18B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
